Scleritodermin A, a cytotoxic cyclic peptide from the lithistid sponge Scleritoderma nodosum

Area of Science:

• Marine natural products chemistry
• Chemical biology
• Pharmacology

Background:

• Marine sponges are a rich source of structurally diverse bioactive compounds.
• The lithistid sponge genus Scleritoderma is known to produce unique metabolites.

Purpose of the Study:

• To isolate and characterize novel compounds from the marine sponge Scleritoderma nodosum.
• To evaluate the biological activity of the isolated compounds, focusing on cytotoxicity and effects on tubulin polymerization.

Main Methods:

• Spectroscopic methods (NMR, MS) were used for structural elucidation of the new cyclic peptide.
• In vitro assays were performed to assess cytotoxicity against human tumor cell lines.
• Tubulin polymerization inhibition assays were conducted.

Main Results:

• A new cyclic peptide, scleritodermin A, was isolated and its structure determined.
• Scleritodermin A incorporates unusual amino acid residues, including keto-allo-isoleucine and O-methyl-N-sulfoserine.
• The novel conjugated thiazole moiety (ACT) was identified as a key structural feature.
• Scleritodermin A demonstrated significant in vitro cytotoxicity against various human tumor cell lines.
• The compound effectively inhibited tubulin polymerization.

Conclusions:

• Scleritodermin A represents a novel cyclic peptide with a unique chemical structure.
• The observed cytotoxicity and tubulin polymerization inhibition suggest potential as an anticancer agent.
• Further investigation into the mechanism of action and therapeutic potential of scleritodermin A is warranted.